Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Increasing confidence in UK beef
Singaporean visitors tour AHVLA laboratories

A team from Singapore's Agri-Food and Veterinary Authority (AVA) have visited the UK in order to gain understanding of our bovine spongiform encephalopathy (BSE) surveillance and control methods.

The aim of the visit was to consider the possibility of opening trade links with each other, to supply "prime" UK beef to Singaporean hotels and restaurants.

Dr Chew Siang Thai, director general of AVA, sent his team to the Animal Health and Veterinary Laboratories Agency (AHVLA) in Weybridge, Surrey, to find out more.

The visit involved discussing BSE with AHVLA scientists, looking at controls and testing regimes, as well as a tour of the transmissible spongiform encephalopathies (TSE) laboratories.

Dr Jim Hope, lead scientist for TSE at the AHVLA, said: "The visit showed the effectiveness of our TSE controls and aimed to increase confidence in UK beef.

"We explained how AHVLA delivers statutory surveillance for BSE, and highlighted our role as an international and EU reference laboratory for TSEs and the role of our experts as European Food Safety Authority consultants."

Dr Hope added that he is "optimistic" the visit will lead to a positive assessment of the UK's BSE controls by the Singapore BSE Technical committee and the AVA Ministry.

"[This will] potentially enable the export of prime UK beef from cattle under 30 months of age by the autumn of this year," he concluded. 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.